Vita-D 200,000 IU Made in Korea Cholecalciferol vitamin D vitamin D3
vitaminD
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- T/T
- Production method
- OEM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- vitamin d, cholecalciferol, vitamin injection
- Category
- Other Beauty Products
Wellspharmtech Co., Ltd.
- Membership
- PRO
- Recent Visit
- Oct 28, 2024
- Country / Year Established
- South Korea / 2007
- Business type
- Distributor
- Verified Certificate
-
3
Product name | Vita-D 200,000 IU Made in Korea Cholecalciferol vitamin D vitamin D3 | Certification | - |
---|---|---|---|
Category | Other Beauty Products | Material | - |
Keyword | vitamin d , cholecalciferol , vitamin injection | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | 1000 |
Supply type | OEM | HS code | - |
Product Information
Vita-D Inj.
200,000IU
Component
Cholecalciferol (EP) in 1mL ----5mg (200,000 IU) [Solvent: medium-chain triglycerides (MCTs), Tocopherol(dl-α-Tocopherol)]
Identification
Colorless to greenish-yellow cholecalciferol emulsion in a brown glass ampoule
Efficacy / Effect
1. Prevention and treatment of vitamin D deficiency in the elderly and adolescents with a high risk of vitamin D deficiency
2. Prevention and treatment of vitamin D deficiency in adults at high risk of vitamin D deficiency with malabsorption
Dosage
Use according to the doctor's prescription but adjust the dose according to the level of 25-hydroxy vitamin D in the blood. Adverse reactions increase with overdose, so do not administer more than necessary.
Adult: As cholecalciferol, 200,000 IU is injected intramuscularly. Adolescent: As cholecalciferol, 200,000 IU is injected intramuscularly.
Elderly: As cholecalciferol, 100,000 IU is injected intramuscularly. The annual dose should not exceed 600,000 IU as cholecalciferol.
Precautions for use
1. Warning
1) To avoid overdose, take treatment containing vitamin D and food intake enhancing vitamin D level into consideration. 2) Observe calcium level; if the level of serum calcium exceeds 10.5mg/dl or urinary calcium in adults exceeds 4mg/kg day, stop dosing. 3) If calcium intake is high, regularly monitor the blood and calcium level.
2. Do not administer this drug to the following patients: 1) Patients with hypersensitivity to the components of this drug 2) Patients with hypercalcemia, hypercalciuria 3) Patients with calcium oxalate stones 4) Patients with renal impairment 5) Patients who are immobilized in a hospital bed 6) Sarcoidosis 7) Patients with pseudoparathyroidism
3. Adverse reaction 1) If overdose, the following adverse reactions may occur: Headache, asthenia, fatigue, muscle pain, Loss of appetite, weight loss, growth disorder, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, high blood pressure, calcium oxalate stones, tissue calcification, kidney disease, vascular disease, and kidney failure. In addition, hypercalcemia, hyperphosphatemia, and hyperphosphateuria may occur.
Storage / Shelf life
Hermetic container, store at room temperature (1~30 ℃ ) in a Light-resistant / 36 months from the date of manufacture
Packing unit
1mL * 5Amp.
B2B Trade
Price (FOB) | Negotiable | transportation | Air Transportation,Express |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
- President
- Na Jin Sang
- Address
- 24 Gasan digital 1-ro Geumcheon-gu Seoul, Geumcheon-gu, Seoul, Korea
- Product Category
- Face Cream & Lotion,Face Mask,Medicines,Other Body Care Products,Shampoo
- Year Established
- 2007
- Company introduction
-
WELLS PHARMTECH CO., Ltd. was founded in 2007. We are leading beauty market with our products such as Glutathione and Lipotocin. We are also expanding the market of medicines with products such as Glutatine and Benfota. We use technology obtained from many clinical trials and researches to develop our cosmetics, drugs and medical devices for human life and health.We want to take care of people's health with the trust and know-how gained from selling to more than 2,000 hospitals and clinics in Korea and over 50 countries in the world.
- Main Markets
-
Chile
France
Indonesia
Philippines
Russia
South Africa
U. Kingdom
U.A.E.
U.S.A
Zimbabwe
- Main Product
- Attached File